Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

The impact of strain-specific immunity on Lyme disease incidence is spatially heterogeneous.

Khatchikian CE, Nadelman RB, Nowakowski J, Schwartz I, Wormser GP, Brisson D.

Diagn Microbiol Infect Dis. 2017 Dec;89(4):288-293. doi: 10.1016/j.diagmicrobio.2017.08.015. Epub 2017 Aug 25.

2.
3.

Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States.

Biggs HM, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, Folk SM, Kato CY, Lash RR, Levin ML, Massung RF, Nadelman RB, Nicholson WL, Paddock CD, Pritt BS, Traeger MS.

MMWR Recomm Rep. 2016 May 13;65(2):1-44. doi: 10.15585/mmwr.rr6502a1.

PMID:
27172113
4.

Public health impact of strain specific immunity to Borrelia burgdorferi.

Khatchikian CE, Nadelman RB, Nowakowski J, Schwartz I, Levy MZ, Brisson D, Wormser GP.

BMC Infect Dis. 2015 Oct 26;15:472. doi: 10.1186/s12879-015-1190-7.

5.

Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.

Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, Cooper D, Nadelman RB, Visintainer P, Schwartz I, Wormser GP.

Clin Infect Dis. 2015 Dec 15;61(12):1800-6. doi: 10.1093/cid/civ735. Epub 2015 Sep 18.

6.

Erythema migrans.

Nadelman RB.

Infect Dis Clin North Am. 2015 Jun;29(2):211-39. doi: 10.1016/j.idc.2015.02.001. Review.

PMID:
25999220
7.

Long-term assessment of health-related quality of life in patients with culture-confirmed early Lyme disease.

Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Molla I, Dornbush R, Visintainer P, Nowakowski J.

Clin Infect Dis. 2015 Jul 15;61(2):244-7. doi: 10.1093/cid/civ277. Epub 2015 Apr 17.

PMID:
25888674
8.

Long-Term Assessment of Fibromyalgia in Patients with Culture-Confirmed Lyme Disease.

Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Farber S, Prakash P, Ash J, Nowakowski J.

Arthritis Rheumatol. 2015 Mar;67(3):837-839. doi: 10.1002/art.38972. Epub 2014 Dec 2.

9.

Long-term assessment of fatigue in patients with culture-confirmed Lyme disease.

Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Nowakowski J.

Am J Med. 2015 Feb;128(2):181-4. doi: 10.1016/j.amjmed.2014.09.022. Epub 2014 Oct 15.

PMID:
25447620
10.

Evidence for strain-specific immunity in patients treated for early lyme disease.

Khatchikian CE, Nadelman RB, Nowakowski J, Schwartz I, Wormser GP, Brisson D.

Infect Immun. 2014 Apr;82(4):1408-13. doi: 10.1128/IAI.01451-13. Epub 2014 Jan 13.

11.

Reinfection versus relapse in Lyme disease.

Nadelman RB, Wormser GP.

N Engl J Med. 2013 Mar 14;368(11):1063-4. doi: 10.1056/NEJMc1215615. No abstract available.

PMID:
23484837
12.

Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease.

Wormser GP, Aguero-Rosenfeld ME, Cox ME, Nowakowski J, Nadelman RB, Holmgren D, McKenna D, Bittker S, Zentmaier L, Cooper D, Liveris D, Schwartz I, Horowitz HW.

J Clin Microbiol. 2013 Mar;51(3):954-8. doi: 10.1128/JCM.02929-12. Epub 2013 Jan 9.

13.

Differentiation of reinfection from relapse in recurrent Lyme disease.

Nadelman RB, Hanincová K, Mukherjee P, Liveris D, Nowakowski J, McKenna D, Brisson D, Cooper D, Bittker S, Madison G, Holmgren D, Schwartz I, Wormser GP.

N Engl J Med. 2012 Nov 15;367(20):1883-90. doi: 10.1056/NEJMoa1114362.

14.

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

Wormser GP, Schriefer M, Aguero-Rosenfeld ME, Levin A, Steere AC, Nadelman RB, Nowakowski J, Marques A, Johnson BJ, Dumler JS.

Diagn Microbiol Infect Dis. 2013 Jan;75(1):9-15. doi: 10.1016/j.diagmicrobio.2012.09.003. Epub 2012 Oct 11.

15.

The amber theory of Lyme arthritis: initial description and clinical implications.

Wormser GP, Nadelman RB, Schwartz I.

Clin Rheumatol. 2012 Jun;31(6):989-94. doi: 10.1007/s10067-012-1964-x. Epub 2012 Mar 13.

PMID:
22411576
16.

Antiscience and ethical concerns associated with advocacy of Lyme disease.

Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Shapiro ED, Sood SK, Steere AC, Weinstein A, Wormser GP.

Lancet Infect Dis. 2011 Sep;11(9):713-9. doi: 10.1016/S1473-3099(11)70034-2.

17.

Quantitation of cell-associated borrelial DNA in the blood of Lyme disease patients with erythema migrans.

Liveris D, Schwartz I, McKenna D, Nowakowski J, Nadelman RB, DeMarco J, Iyer R, Cox ME, Holmgren D, Wormser GP.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):791-5. doi: 10.1007/s10096-011-1376-x. Epub 2011 Aug 16.

PMID:
21842448
18.

Prospective evaluation of 2009 H1N1 influenza A in patients admitted with fever to an oncology unit.

Seiter K, Shah D, Sandoval C, Liu D, Nadelman RB, Sinaki B, Cuffari C, Shi Q, Abid S, Montecalvo M.

Infect Control Hosp Epidemiol. 2011 Aug;32(8):815-7. doi: 10.1086/661105.

PMID:
21768767
19.

Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii.

Strle F, Ružić-Sabljić E, Logar M, Maraspin V, Lotrič-Furlan S, Cimperman J, Ogrinc K, Stupica D, Nadelman RB, Nowakowski J, Wormser GP.

Vector Borne Zoonotic Dis. 2011 Sep;11(9):1253-8. doi: 10.1089/vbz.2010.0230. Epub 2011 May 25.

PMID:
21612533
20.

Babesiosis in Lower Hudson Valley, New York, USA.

Joseph JT, Roy SS, Shams N, Visintainer P, Nadelman RB, Hosur S, Nelson J, Wormser GP.

Emerg Infect Dis. 2011 May;17(5):843-7. doi: 10.3201/eid1705.101334.

21.

Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism.

Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Sood SK, Weinstein A, Wormser GP.

J Med Ethics. 2011 Feb;37(2):68-73. doi: 10.1136/jme.2009.032896. Epub 2010 Nov 21.

PMID:
21097940
22.

Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis.

Warshafsky S, Lee DH, Francois LK, Nowakowski J, Nadelman RB, Wormser GP.

J Antimicrob Chemother. 2010 Jun;65(6):1137-44. doi: 10.1093/jac/dkq097. Epub 2010 Apr 9.

PMID:
20382722
23.

Novel influenza A (H1N1) in patients with hematologic malignancies.

Seiter K, Nadelman RB, Liu D, Ahmed T, Montecalvo MA.

J Clin Oncol. 2010 Jan 20;28(3):e27-9. doi: 10.1200/JCO.2009.25.8889. Epub 2009 Dec 14. No abstract available.

PMID:
20008619
24.
25.

Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States.

Nowakowski J, McKenna D, Nadelman RB, Bittker S, Cooper D, Pavia C, Holmgren D, Visintainer P, Wormser GP.

Clin Infect Dis. 2009 Dec 1;49(11):1733-5. doi: 10.1086/648076.

PMID:
19886794
26.

Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatment.

Wormser GP, Shapiro ED, Halperin JJ, Porwancher RB, O'Connell S, Nadelman RB, Strle F, Radolf JD, Hovius JW, Baker PJ, Fingerle V, Dattwyler R.

Minerva Med. 2009 Apr;100(2):171-2. No abstract available.

PMID:
19390504
27.

Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease.

Wormser GP, Brisson D, Liveris D, Hanincová K, Sandigursky S, Nowakowski J, Nadelman RB, Ludin S, Schwartz I.

J Infect Dis. 2008 Nov 1;198(9):1358-64. doi: 10.1086/592279.

28.

Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease.

Wormser GP, Nowakowski J, Nadelman RB, Visintainer P, Levin A, Aguero-Rosenfeld ME.

Clin Vaccine Immunol. 2008 Oct;15(10):1519-22. doi: 10.1128/CVI.00109-08. Epub 2008 Aug 20.

29.

The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans.

Dykhuizen DE, Brisson D, Sandigursky S, Wormser GP, Nowakowski J, Nadelman RB, Schwartz I.

Am J Trop Med Hyg. 2008 May;78(5):806-10.

30.

Erythema migrans.

Dandache P, Nadelman RB.

Infect Dis Clin North Am. 2008 Jun;22(2):235-60, vi. doi: 10.1016/j.idc.2007.12.012. Review.

PMID:
18452799
31.

A critical appraisal of "chronic Lyme disease".

Feder HM Jr, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP; Ad Hoc International Lyme Disease Group, Agger WA, Artsob H, Auwaerter P, Dumler JS, Bakken JS, Bockenstedt LK, Green J, Dattwyler RJ, Munoz J, Nadelman RB, Schwartz I, Draper T, McSweegan E, Halperin JJ, Klempner MS, Krause PJ, Mead P, Morshed M, Porwancher R, Radolf JD, Smith RP Jr, Sood S, Weinstein A, Wong SJ, Zemel L.

N Engl J Med. 2007 Oct 4;357(14):1422-30. Review. No abstract available. Erratum in: N Engl J Med. 2008 Mar 6;358(10):1084. Agger, WA [added]; Artsob, H [added]; Auwaerter, P [added]; Dumler, JS [added]; Bakken, JS [added]; Bockenstedt, LK [added]; Green, J [added]; Dattwyler, RJ [added]; Munoz, J [added]; Nadelman, RB [added]; Schwartz, I [added]; Draper, T [added]; McSweegan,.

PMID:
17914043
32.

Reinfection in patients with Lyme disease.

Nadelman RB, Wormser GP.

Clin Infect Dis. 2007 Oct 15;45(8):1032-8. Epub 2007 Sep 11. Review.

PMID:
17879922
33.

Human granulocytic anaplasmosis during pregnancy: case series and literature review.

Dhand A, Nadelman RB, Aguero-Rosenfeld M, Haddad FA, Stokes DP, Horowitz HW.

Clin Infect Dis. 2007 Sep 1;45(5):589-93. Epub 2007 Jul 30. Review.

PMID:
17682993
34.

Single-dose prophylaxis against Lyme disease.

Wormser GP, Dattwyler RJ, Shapiro ED, Dumler JS, O'Connell S, Radolf JD, Nadelman RB.

Lancet Infect Dis. 2007 Jun;7(6):371-3. No abstract available.

PMID:
17521588
35.

The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB.

Clin Infect Dis. 2006 Nov 1;43(9):1089-134. Epub 2006 Oct 2. Erratum in: Clin Infect Dis. 2007 Oct 1;45(7):941.

PMID:
17029130
36.

Response to meta-analysis of Lyme borreliosis symptoms.

Shapiro ED, Dattwyler R, Nadelman RB, Wormser GP.

Int J Epidemiol. 2005 Dec;34(6):1437-9; author reply 1440-3. Epub 2005 Nov 30. No abstract available.

PMID:
16319106
37.

Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions.

Wormser GP, Masters E, Nowakowski J, McKenna D, Holmgren D, Ma K, Ihde L, Cavaliere LF, Nadelman RB.

Clin Infect Dis. 2005 Oct 1;41(7):958-65. Epub 2005 Aug 31.

PMID:
16142659
38.

Brief communication: hematogenous dissemination in early Lyme disease.

Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D, Byrne DW, Nowakowski J.

Ann Intern Med. 2005 May 3;142(9):751-5.

PMID:
15867407
39.

Microbiologic evaluation of patients from Missouri with erythema migrans.

Wormser GP, Masters E, Liveris D, Nowakowski J, Nadelman RB, Holmgren D, Bittker S, Cooper D, Wang G, Schwartz I.

Clin Infect Dis. 2005 Feb 1;40(3):423-8. Epub 2005 Jan 10.

40.

Poly-ticks: Blue State versus Red State for Lyme disease.

Nadelman RB, Wormser GP.

Lancet. 2005 Jan 22-28;365(9456):280. No abstract available.

PMID:
15664208
41.

Lyme disease and the heart.

Haddad FA, Nadelman RB.

Front Biosci. 2003 Sep 1;8:s769-82. Review.

PMID:
12957829
42.

Long-term follow-up of patients with culture-confirmed Lyme disease.

Nowakowski J, Nadelman RB, Sell R, McKenna D, Cavaliere LF, Holmgren D, Gaidici A, Wormser GP.

Am J Med. 2003 Aug 1;115(2):91-6.

PMID:
12893393
43.

Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial.

Wormser GP, Ramanathan R, Nowakowski J, McKenna D, Holmgren D, Visintainer P, Dornbush R, Singh B, Nadelman RB.

Ann Intern Med. 2003 May 6;138(9):697-704.

PMID:
12729423
44.

Duration of treatment for Lyme borreliosis: time for a critical reappraisal.

Wormser GP, Nowakowski J, Nadelman RB.

Wien Klin Wochenschr. 2002 Jul 31;114(13-14):613-5. Review.

PMID:
12422611
45.

Recognition and treatment of erythema migrans: are we off target?

Nadelman RB, Wormser GP.

Ann Intern Med. 2002 Mar 19;136(6):477-9. No abstract available.

PMID:
11900501
46.

Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques.

Nowakowski J, Schwartz I, Liveris D, Wang G, Aguero-Rosenfeld ME, Girao G, McKenna D, Nadelman RB, Cavaliere LF, Wormser GP; Lyme Disease Study Group.

Clin Infect Dis. 2001 Dec 15;33(12):2023-7. Epub 2001 Nov 7.

PMID:
11700579
47.

Asymptomatic Borrelia burgdorferi infection.

Wormser GP, Nadelman RB, Nowakowski J, Schwartz I.

Med Hypotheses. 2001 Oct;57(4):435-8.

PMID:
11601865
48.

Yield of large-volume blood cultures in patients with early Lyme disease.

Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelman RB, Pavia C.

J Infect Dis. 2001 Oct 15;184(8):1070-2. Epub 2001 Aug 29.

PMID:
11574924
49.

Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite.

Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, McKenna D, Welch P, Marcus R, Agüero-Rosenfeld ME, Dennis DT, Wormser GP; Tick Bite Study Group.

N Engl J Med. 2001 Jul 12;345(2):79-84.

50.

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America.

Wormser GP, Nadelman RB, Dattwyler RJ, Dennis DT, Shapiro ED, Steere AC, Rush TJ, Rahn DW, Coyle PK, Persing DH, Fish D, Luft BJ.

Clin Infect Dis. 2000 Jul;31 Suppl 1:1-14. No abstract available.

PMID:
10982743

Supplemental Content

Loading ...
Support Center